Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo.
about
The Antimicrobial Peptides P-113Du and P-113Tri Function against Candida albicans.CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein.Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.Human microtubule-associated protein tau mediates targeted killing of CD30(+) lymphoma cells in vitro and inhibits tumour growth in vivo.Novel EGFR-specific immunotoxins based on panitumumab and cetuximab show in vitro and ex vivo activity against different tumor entities.Antimalarial activity of granzyme B and its targeted delivery by a granzyme B-single-chain Fv fusion protein.Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in vitro and in vivoElimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins.CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL.Human MAP Tau Based Targeted Cytolytic Fusion Proteins.Designing the Sniper: Improving Targeted Human Cytolytic Fusion Proteins for Anti-Cancer Therapy via Molecular Simulation.Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.
P2860
Q37287922-7E06E515-6605-4DE7-B3B1-4AD9E6C1D557Q37687139-D0061310-373F-4FDB-B0D1-F4E1BFEBBD49Q38680881-241C246E-8574-4FB1-A2AC-7586B026FF20Q38698179-98703626-5298-4686-9A10-EC88EA7E755BQ38781425-783DAC47-149B-4DC7-ABB3-18A01C496DDFQ38927751-9CB581EF-12D2-4258-BBEB-7B231355A1A6Q38936986-19B43357-E592-46AC-9A2D-7AD3531E6BDAQ39069677-F220B349-DC00-4104-A57D-96DFC763E35FQ41033340-E8518B72-3988-4DA8-BBFE-25C4DD1A7FA8Q41702248-F9AD50E5-D1EB-44B5-A070-FF1D4A4D595DQ41964470-899A3D10-3695-4C99-B7B3-7950293E2514Q47430608-FC8A8AE6-C343-40F6-992B-3EDFBEE25756Q50918966-C19913FB-7530-49C0-AF88-28AF65383DDDQ50921086-982B7651-2389-42C8-B535-0CFFB7191849Q50985152-47C72097-0EA8-4BED-B933-4A6CD35DDBB0Q51314320-3F0E4D2B-E9A8-4324-8770-70745802D5BFQ53076778-339AECAA-9CCF-44BF-B798-92FA29AF406C
P2860
Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@en
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@nl
type
label
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@en
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@nl
prefLabel
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@en
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@nl
P2093
P2860
P356
P1476
Microtubule-associated protein ...... ft mouse tumour model in vivo.
@en
P2093
D Hristodorov
R Mladenov
P2860
P2888
P304
P356
10.1038/BJC.2013.457
P407
P50
P577
2013-08-13T00:00:00Z